QNCX

Quince Therapeutics, Inc.

Healthcare · Biotechnology

$40.35 sample

-0.58 (-1.42%) 1D

Market cap

$45.3B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-29

Alerts

8

Price$40.35 -1.68% 3M daily closessample

42.8139.10

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 29SEC10-Q filed
Sep 22SEC8-K filed: material event
Sep 17INSInsider sell: 10% owner
Sep 11SECDEF 14A filed
Sep 08SEC10-Q filed
Sep 03INSInsider sell: General Counsel
Aug 28INSInsider sell: Chief Financial Officer
Aug 24INSInsider buy: Chief Financial Officer

Sign up to see the real QNCX record →

Company facts

SEC EDGAR registration

Name: Quince Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -57sample, -100 to +100
Reporting currency: USD

Who is positioning in QNCX

sample

Insiders: 17 insider transactions over 90 days, net selling, $440.7M
Congress: 1 members traded over 90 days
Institutions · 13F: 42 funds hold $295.3M
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$1.4B +12.3% y/y

Q4 2024Q3 2026

Inventory$853.6M +15.3% y/y

Q4 2024Q3 2026

Accounts receivable$655.3M +18.0% y/y

Q4 2024Q3 2026

Total debt$1.7B +12.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $35.4B -1.8% 3M
Sample peer B: $13.7B -1.6% 3M
Sample peer C: $38.2B -13.4% 3M
Sample peer D: $9.3B -5.5% 3M
Sample peer E: $8.9B -3.5% 3M